UTHR.NASDAQUnited Therapeutics CORP
Form 4: United Therapeutics Director Nilda Mesa Reports Stock Transactions
Sentiment:
SEC Form 4 Filing
Director Nilda Mesa reports the vesting of restricted stock units and subsequent conversion into common stock of United Therapeutics.
Summary
- On July 13, 2024, Nilda Mesa, a director of United Therapeutics Corp, had 900 restricted stock units vest.
- These units were converted into 900 shares of common stock at a price of $0 per share.
- Following the transaction, Mesa directly owns 6,007 shares of United Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock transactions by a company director, indicating a neutral sentiment.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves the vesting of previously granted equity compensation.
Key Dates
| Date | Description |
|---|---|
| 07/13/2024 | Date of transaction: vesting of restricted stock units and conversion to common stock. |
| 07/15/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.